Brief

Boston Metro Life Science VC Funding - 2022 Recap

January 10, 2023

Looking for a PDF of this content?

Download

  • The Boston Metro area ended 2022 with $6.7 billion in life science Venture Capital funding, with the fourth quarter totalling $1.8 billion.
     
  • The $6.7 billion raised in 2022 was the second highest annual total raised behind 2021.
     
  • The fourth quarter recorded $600 million more funding than the third quarter, but was on par with the first and second quarters of the year
     
  • Series B funding saw the steepest decrease when compared to 2021 numbers, falling 68%. Seed funding and Series A funding also saw decreases, 39% and 22% respectively.
     
  • 2022 funding was a 40% increase when compared to the 2019/2020 average.